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Abstract 
Urolithiasis is a painful disease that affects the human population in every part of the world and majority of cases 
of renal lithiasis have calcium oxalate. The present study was carried out to study effect of M. malabathricum on 
calcium oxalate crystals in vitro and to determine the relationship between total flavonoid content and anti-
crystallization activity of different extract. Four different extract from different parts of M. malabathricum were 
studied to determine the part with higher activity against calcium oxalate crystallization.The leaf of M. 
malabathricum demonstrated the highest crystal growth inhibition activity compared to other parts of the plant. 
The leaf extract was further fractionated by column chromatography. The fractions were studied for total 
flavonoid content as well as crystal growth inhibition and Spearman correlation showed that there was a good 
correlation between TFC and antilithiasis activity with the F1 fraction having highest activity. The activity of the 
F1 fraction was confirmed by calcium oxalate aggregation assay and microscopic examination. The higher 
content of flavonoids and calcium oxalate antilithiasis activity of the leaves suggest further studies for 
development of newer effective drugs from this herb. 
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1. Introduction 
The term lithiasis is  referred to as the process of stone formation (Prywer & Torzewska, 2012). Stone usually 
affects different parts of the body such as calyx (upper, middle or lower part), renal pelvis, ureter (upper, middle 
or distal part) and urinary bladder. The formation of stone in the renal system is called urolithiasis. This disease 
affects a wide range of the population but up to  now, despite advances in technological medical approach there 
is no satisfactory drug used in the treatment, prevention and reoccurrence of the disease (Butterweck & Khan, 
2009). Up to 20% of the world population are suffering from urinary stone (Benramdane et al., 2008), Many 
parts of the world are suffering from urolithiasis, Malaysia is not excluded in terms of prevalence and incidence 
since it appears to show the same trend as in other developed countries (Sreenevasan, 1990). However despite its 
long history, economic drawback and mortality by this disease, there is no complete cure for this disease.  Many 
plants claimed to have used for renal diseases were found to exhibit positive action (Sekkoum et al., 2010). The 
majority of stones are composed of calcium oxalate (Prywer & Torzewska, 2012). 
Herbal medicinal plants have been used for the treatment of diseases since ancient time. In addition, it 
serves as important part of primary health care. Medicinal plants serve as important source of drug development 
and are also used traditionally to treat kidney stone. 
It was also reported that citrus aurantifolia, Centella asiatica L, Vernonia conferta Benth, Vernonia 
guineensis Benth, Brassica oleracea L., Canarium schweinfurthii Engl, Garcinia kola Heckel, Jatropha curcas 
L., Ricinodendron heudelotii (Baill.) Pierre ex Pax, Guarea cedrata (A. Chev.) Pellegr., Albizia adianthifolia 
(Schum.) W.F. Wight, Coula edulis Baill./Ebwelle, Ongokea gore (Hua) Pierre, Eleusine indica (L.) Gaertn, 
Oryza sativa L., Zea mays L., Hallea ciliata (Aubr. & Pellegr.) Leroy, Fagara macrophylla (Oliv.) Engl. syn, 
Zanthoxyllum macrophyllum Oliv, Baillonella toxisperma Pierre, Cola lateritia K. Schum and Erismadelphus 
exsul Mildbr. Var. platyplyllus were used by the people of Littoral Region, Cameroon as medicinal recipes in the 
treatment of urinary lithiasis (Noumi and Ebwelle 2011). However, there is no satisfactory drug to be use in 
clinical therapy, especially for the prevention and recurrence of stones (Butterweck & Khan, 2009). Since many 
medicinal plants were reported to have been used traditionally for the treatment of lithiasis, M. malabathricum 
was reported to have to have effect on renal disease in traditional medicine (Joffry et al., 2012). In line with this 
and also due to the reach chemical content of M. malabathricum the plant could be an important source in the 
management of lithiasis. Additionally, despite several studies carried out to assess the pharmacological activities 
of M. malabathricum there is no study conducted to find out whether the plant has inhibitory action on the 
growth of calcium oxalate crystals. 
This study aimed to determine the inhibitory effects of calcium oxalate crystals growth by leaf, flower, fruit 
and stem of M. malabathricum. And to determine the relationship between total flavonoid content and anti-
crystallization activity of different extracts.  
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2. Materials and methods 
2.1 Chemical and Reagents 
The chemicals, biochemicals and solvents used in this study were of analytical grade. These include: chloroform, 
ethanol, ethyl acetate, methanol sodium carbonate solution, methanol, aluminium chloride, sodium chloride, 
trisodium citrate dihydrate, disodium oxalate and silica gel 0.060-0.20mm all obtained from Merck, Germany. 
However, tris-hydroxymethylmethalamine (Tris) was obtained from Fisher Scientific UK. Calcium chloride 
dihydrate was obtained from Duchefa, Netherland. 
 
2.2 Plant materials  
M. malabathricum samples consisting of leaf, flower, fruit and stem were collected between April and August 
2014 from the health forest Terengganu,  Malaysia. The samples were identified by Science officer; 
Noorhaslinda Haron and deposited with the specimen vouchers 00244 in the Herbarium Unit, Department of 
Agriculture and Biotechnology, Faculty of Bioresources and Food Industry, Universiti Sultan Zainal Abidin 
(UniSZA). 
 
2.3 Morphological Examination 
Initially, the samples were checked by visual examination for basic macroscopic features such as length, shape, 
colour and odour. 
 
2.4 Preparation of Extracts 
The plant samples consisting of different parts (flower, leaf, fruit, and stem) were washed with tap water, then 
rinsed with distilled water and dried at 40°C. The samples were ground into powder form, and each powdered 
sample was weighed 600 g and soaked in methanol at the ratio of 1:10 (w/v) for 72 h. The extracts were 
decanted and filtered through Whatman filter paper no. 1. The filtrate was then concentrated in a rotary 
evaporator at low temperature 40°C and reduced pressure. The extracts were dried at 40°C and kept in a freezer 
at 4°C for further use.  
A dried methanol extract (20 g) of M. malabathricum leaf was mixed with equal amount of silica gel and 
left to dry. The dried mixture was submitted to the column chromatography packed with silica gel earlier. The 
series of organic solvents with increasing polarity have been used starting with ethyl acetate (100%), followed by 
ethyl acetate : methanol at different ratios of (9 : 1), (8 : 2), (7 : 3) (6 : 4) and ending by 100% methanol. The 
fractions were collected in test tubes and combined based on the colour and similar profile on Thin Layer 
Chromatography. Eleven fractions were collected and coded as F1 to F11 respectively. The fractions were 
evaporated in a rotatory evaporator under reduced pressure at low temperature 35°C. The fractions were dried at 
35°C in an oven and kept in a freezer at 4°C for further use. 
The extracts of different part of M. malabathricum (leaf, flower, fruit and stem), sodium citrate and 
fractions of leaf (F1-F11) were prepared at 100 µg/mL using sodium chloride solution (0.15 M). Additionally, 
calcium chloride and sodium oxalate solutions at 40 mM and 4 mM respectively were also prepared using 
sodium chloride solution (0.15 M). 
 
2.5 Total Flavonoid Content 
The flavonoid content of different fractions of leaf of M. malabathricum obtained from column chromatography 
was determined according to the method of Moreno et al. (2000), with slight modifications. An aliquot of the 
extract measuring 0.25 mL in methanol at the concentration of 200 µg/mL was mixed with solution containing 
50 µL of 10% aluminium chloride, 50 µL of 1 M aqueous potassium acetate and 2.15 mL of 95% ethanol. The 
mixtures were incubated at room temperature for 40 min and then the absorbance was recorded 
spectrophotometrically at 415 nm. The total flavonoid was calculated using quercetin as a standard and 
expressed as mg/g from the calibration curve. 
 
2.6 Statistical Analysis 
For total flavonoid content the experiments were carried out in triplicate and expressed as means ± SD. The data 
for the inhibition of calcium oxalate crystal growth and aggregation were expressed as mean ± standard error of 
mean (SEM). The means were compared by one-way ANOVA, and the values were considered to be 
significantly different at P<0.05. Spearman Correlation was used to estimate the interrelationship between TFC 
and antilithiasis activity of different fractions of M. malabathricum leaf. 
 
2.7 Study of Inhibition of Calcium Oxalate Crystal Growth 
Study of calcium oxalate crystallization in the absence of inhibitor has been carried out using two separate 
solutions of calcium chloride (40 mM) and sodium oxalate (4 mM). These solutions were prepared using sodium 
chloride solution (0.15 M) buffered with Tris 0.05 M at pH 6.8. A volume of 80 µL of 40 mM calcium chloride 
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was transferred into the well, and then to this, 80 µL of 4 mM sodium oxalate was added. The mixture was 
shaken to prevent sedimentation. The measurement of absorbance was immediately taken at 620 nm using 
Infinite M200 PRO TECAN and is continued for a period of 10 min. The solution of calcium chloride of 40 mM 
was used as blank and for each experiment,six replicates were taken. The data was used as the uncontrolled 
growth of the stone nucleus for the comparison of growth in the presence of the standard drugs and plant extract. 
The study was then carried out to assess the effect of plant extract and standard drug against stone nucleus 
formation. Plant extract and standard drug (sodium citrate) were used as inhibitors 
Eighty µL of calcium chloride (40 mM) solution, prepared using sodium chloride solution (0.15 M) was  
transferred into the well (96 plate) and to this,  80 µL inhibitor (100 µg/mL) was added and also 80 µL of 
sodium oxalate (4 mM) was added to the mixture in wells, buffered with Tris 0.05 M at pH 6.8. The 
measurement of absorbance for the change in turbidity of the solution was immediately taken at 620 nm using 
Infinite M 200 PRO TECAN and continued for a period of 10 min with the mixture shaken to prevent 
sedimentation. The solution of calcium chloride (40 mM) and the inhibitor was used as blank. Each experiment 
was replicated six times and absorbance was recorded. The data was used as controlled growth of the stone 
nucleus. The data for both studies were compared, and the percentage inhibition of stone nucleus formation 
(crystallization) was calculated using the graphical method, using the equation below. 
 
A = Turbidimetric slop in the presence of inhibitor. 
B = Turbidimetric slop in the absence of inhibitor. 
CaCl2 + Na2C2O4 → CaC2O4 + 2NaCl 
 
2.8 Aggregation Study on Calcium Oxalate Crystals 
The study was carried out according to the method of Galani and Panchal (2014) with minor modifications. For 
the formation of calcium oxalate crystals, solution of calcium chloride and sodium oxalate at 50 mM were mixed 
and equilibrated at 60°C in a water bath for 1 h and cooled at 37°C for 24 h. The calcium oxalate crystals were 
collected and evaporated at 37°C. The calcium oxalate was weighed and prepared with sodium chloride at 1000 
µg/mL and buffered with Tris 0.05 M (pH 6.8). The absorbance was taken at 620 nm for both in the presence 
and absence of inhibitor (100 µg/mL).  
The percentage inhibition was calculated using the following formula:  
 
A =Turbidimetric slope in the presence of inhibitor 
B =Turbidimetric slope in the absence of inhibitor 
 
2.9 Microscopic Study of Calcium Oxalate Crystals 
The calcium oxalate crystals growth inhibition study of M. malabathricum was also carried out with the aid of 
microscopic examination. 
 
2.10 Preparation of Slide in the Presence of Inhibitor 
Small amount of calcium oxalate solution (1 mg/mL) buffered with Tris 0.05 M (pH 6.8) was place on to the 
slide and observed under light microscope. 
 
2.11 Preparation of Slide in the Absence of Inhibitor 
Small amount of solution containing equal amount calcium oxalate crystal (1 mg/mL) buffered with Tris 0.05 M 
(pH 6.8) and 100 ug/mL of either sodium citrate or extract of M. malabathricum was place on to the slide and 
observed under light microscope. 
 
2.12 Microscopic Examination 
The photographs of calcium oxalate crystals formed in the presence and absence of inhibitors, were observed 
using a light microscope (Olympus Microscope, BX43F-CCD), equipped with digital camera (Olympus DP21) 
and connected to a computer. The photographs were taken at times ten (10×) magnification objective lens. 
 
3. RESULTS AND DISCUSSION  
3.1 Morphology of M. malabathricum (Physical examination) 
The variety of M. malabathricum used in this study has flowers with dark purple magenta petals and yellow 
pistil. The plant grows up to 1.8 meter in height. The leaves are odourless, dark green, ovale with average length 
and width measuring 12.5 -16 cm and 2.9-4.5 cm respectively and Figure 1. (a) shows the pictures of a leaf. The 
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fruits of the plant are purple in colour and oval in shape and when burst reveal sticky dark purple mass with 
orange seeds. Stem is reddish brown in colour. These findings are similar to the finding of Joffry et al. (2012). 
The colour of dried powdered leaf and fruit are pale green and red respectively whereas the colour of powdered 
dried stem and flower is brown and purple respectively. The picture of flower and seed of M. malabathricum is 
shown in Figure 1. (b) whereas the pictures of a close ups of the plant are shown in Figure 1. (c). 
   
                    (a)                                                    (b)                                                      (c) 
Figure 1. (a) Leaf of M. malabathricum, (b) Flower and fruit of M. malabathricum, (c) M. malabathricum plant 
 
3.2 Total Flavonoid Content of Leaf Fractions 
The TFC of leaf fractions obtained from column chromatography are presented in Table 1. and the result is 
expressed in terms of quercetin equivalent from the calibration curve equation: y = 0.0046x + 0.0885, R² = 
0.9941. All fractions were found to contain flavonoid. F1 to F5 are less polar fractions (100% ethyl acetate), and 
they exhibited high flavonoid content. The F6-F9 are the mixtures of less polar and polar solvents (mixture of 
ethyl acetate and methanol) whereas F10 and F11 contain polar solvent (100% methanol) and these fractions 
showed low flavonoids content. The fraction with the highest flavonoid content was F1 with average TFC of 
156.63 mg of QE per gram of extract. One-way ANOVA showed that, the flavonoid content is significantly 
different (p < 0.05) among fractions of M. malabathricum leaf. The post hoc test was carried out using Scheffe 
method. 
Table 1. Total flavonoid content of fractions of M. malabathricum leaf extract 
Fractions TFC (mg QE/ g of extract) 
F1 150.63 ± 16.89e 
F2 108.24 ± 12.03cde 
F3 122.55 ± 12.23de 
F4 120.38 ± 28.74de 
F5 79.98 ± 4.43bcd 
F6 58.61 ± 4.53abc 
F7 42.48 ± 6.80ab 
F8 70.74 ± 4.36abcd 
F9 28.71 ± 1.37ab 
F10 15.67 ± 5.76a 
F11 57.70 ± 31.64abc 
Data are expressed as mean ± SD. Data with different lower case letters on each part of the plant are significantly 
different (p < 0.05). The mean flavonoid content with identical alphabets show no significant difference (p < 
0.05) 
3.3 Crystallization of Calcium Oxalate 
Crystallization study was carried out in the presence and absence of inhibitors. The study showed that, the 
extracts of different parts of M. malabathricum at 100 µg/mL inhibited calcium oxalate crystals formation. The 
leaf exhibited highest percentage of inhibition (90.63%) for calcium oxalate crystal formation and is statistically 
similar to that of positive control of sodium citrate (Table 2.), whereas stem showed lowest percentage of 
inhibition (63.02%) of calcium oxalate formation. However, the rate of crystallization of calcium oxalate crystals 
is statistically significant (p < 0.005) between different parts of M. malabathricum. Additionally, the effect of 
this plant on calcium oxalate crystallization may be associated with its high flavonoid content. 
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Table 2. Percentage inhibition of calcium oxalate crystallization of different parts of M. malabathricum 
Sample Percentage of inhibition (%) 
Negative control 0 
Positive control 95.31 ± 4.04b 
Leaf 90.63 ± 3.86b 
Flower 84.38 ± 2.05ab 
Fruit 66.40 ± 6.35a 
Stem 63.02 ± 6.62a 
Data are reported as the mean ± SEM of six replicates. The values with different letters are significantly different 
(p < 0.05) compared to the remaining groups 
As a result of promising effects of methanol extract of leaf of M. malabathricum, further fractionation of the 
leaf extract was carried out. Eleven fractions of leaves were obtained from column chromatography, and each 
fraction was tested against calcium oxalate crystallization. F1 and F9 exhibited highest and lowest rate of 
inhibition of calcium oxalate crystallization respectively (Table 3.). It was found that most of the extracts 
inhibited the calcium oxalate crystallization not later than 10 min because there is no significant increase in the 
change of turbidity after 10 min. However, F1, F2 and sodium citrate inhibit crystallization of calcium oxalate 
crystal at 1 min. Consequently, the percentage of inhibition of nucleation of calcium oxalate crystals is 
statistically significant (p < 0.005) between different fractions. The Spearman correlation shows that, there is 
excellent significant correlation between TFC and percentage of inhibition of calcium oxalate crystallization 
with r = 0.812, p = 0.002. The finding of this study revealed that, there is an association between the TFC and 
antilithiasis activity in in vitro turbidimetry study of calcium oxalate. For this reason, it can  be suggested that 
flavonoid compounds played important role in  the inhibition  of calcium oxalate crystals formation, and this is 
in line with the finding of Zhari et al. (1999).  M. mabathricum is reported to have high flavonoid, and several 
flavonoids compounds such as kampferol, quercetin, quercitrin were isolated from this plant (Susanti et al., 
2008). The results of its antilithiasis activity may be due to any of these compounds. 
Table 3. Percentage of inhibition of calcium oxalate crystallization for different fractions of M. malabathricum 
Fractions Percentage of Inhibition (%) 
Sodium Citrate  91.44 ± 5.73b 
F1 88.07 ± 11.46ab 
F2 54.51 ± 10.72ab 
F3 59.46 ± 5.46ab 
F4 59.01 ± 12.04ab 
F5 53.60 ± 8.31ab 
F6 53.83 ± 11.29ab 
F7 49.11 ± 12.42ab 
F8 63.75 ± 9.90ab 
F9 19.15 ± 13.72a 
F10 30.41 ± 15.95ab 
F11 58.11 ± 8.42ab 
Data are reported as the mean ± SEM of six replicates. The values with different letters are significantly different 
(p < 0.05) compared to the remaining groups 
 
3.4 Aggregation of Calcium Oxalate 
The aggregation of calcium oxalate was tested with fraction (F1) that had best activity on inhibition of calcium 
oxalate crystallization. The F1 fraction which had better activity inhibited the aggregation of already formed 
calcium oxalate crystals by 66.88%, whereas positive control (sodium citrate is used as positive control) 
inhibited the aggregation of calcium oxalate crystals by 76.33%. In addition to calcium oxalate crystal growth 
inhibition, M. malabathricum had also inhibited crystal aggregation. Therefore, the combined effect on 
crystallization, growth and aggregation is a clear indication that, M. malabathricum has antilithiasis activity in 
vitro. 
 
3.5 Microscopic Examination  
The microscopic examination of calcium oxalate crystals supported the turbidimetric assay. It has been shown in 
Figure 2. that there is high calcium oxalate crystals formation in the absence of sodium citrate.  However, the 
photographs of Figure 3. showed very low formation of calcium oxalate in the presence of sodium citrate 
positive control and plant extracts. Both F1 fraction and sodium citrate inhibited crystallization and aggregation 
of calcium oxalate. 
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Figure 2. Photographs of calcium oxalate crystals in absence of sodium citrate (10×) 
 
 
(a) 
 
(b) 
Figure 3. Photograph of calcium oxalate crystals in presence of (a) positive control of sodium citrate and (b) 
extract of M. malabathricum at 100 ug/mL (10×) 
Both extracts of different parts of M. malabathricum and fractions of the leaf of M. malabathricum 
significantly inhibited the growth of calcium oxalate crystals by inhibition of crystallization and aggregation 
process. Therefore, the effect of M. malabathricum on calcium oxalate is similar to that of Centratherum 
antihelminticum seeds as it inhibited crystallization and aggregation of calcium in vitro (Galani & Panchal, 
2014). According to the finding of this study, phenolic compounds especially flavonoids play a vital role in 
antilithiasis activity as shown by excellent correlation. Moreover, the parts of M. malabathricum with high total 
phenolic content and antioxidant potential were found to have high antilithiasis activity. In addition, the 
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antioxidant activity of M. malabathricum (Danladi et al., 2015) may partly explain its mechanism of antilithiasis 
activity. 
 
4. CONCLUSION 
This study shows that leaf of M. malabathricum inhibit all three step (crystallization, growth and aggregation) of 
calcium oxalate dihydrate crystals formation in vitro. Furthermore, the flavonoid compounds were founds to play 
an important role in preventing the crystallization and aggregation of calcium oxalate dihydrate crystals. The 
kidney stone formation involved three steps; crystallization, growth and aggregation. Therefore, M. 
malabathricum is suggested to be a potent antilithiasis agent as a result of its significant inhibitory effect against 
calcium oxalate crystals, which is the major cause of renal lithiasis. There is a need to carry out in vivo study, 
because, the exact mechanism of the initiation of the calcium oxalate stone formation is not completely 
understood. Additionally, not only excess calcium and oxalate crystals are contributing to the formation stone 
but other foreign body also played a role. It is also important to isolate the active chemical compound(s) 
responsible for this important therapeutic effect and to determine it is mechanism of action. 
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